Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neuronal Protein Tyrosine Phosphatase 1B Hastens Amyloid β-Associated Alzheimer's Disease in Mice
Konrad M. Ricke, Shelly A. Cruz, Zhaohong Qin, et al.
Journal of Neuroscience (2020) Vol. 40, Iss. 7, pp. 1581-1593
Open Access | Times Cited: 52

Showing 1-25 of 52 citing articles:

Antidiabetic agents as a novel treatment for Alzheimer’s and Parkinson’s disease
Joseph Nowell, Eleanor G Blunt, Dhruv Gupta, et al.
Ageing Research Reviews (2023) Vol. 89, pp. 101979-101979
Open Access | Times Cited: 84
New Insights into the Roles and Mechanisms of Spermidine in Aging and Age-Related Diseases
Yu‐Qing Ni, You‐Shuo Liu
Aging and Disease (2021) Vol. 12, Iss. 8, pp. 1948-1948
Open Access | Times Cited: 68
Targeting protein phosphatases for the treatment of inflammation-related diseases: From signaling to therapy
Jie Pan, Lisha Zhou, Chenyang Zhang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 61
Therapeutic Application of Lantibiotics and Other Lanthipeptides: Old and New Findings
Anton D. van Staden, Winschau F. van Zyl, Marla Trindade, et al.
Applied and Environmental Microbiology (2021) Vol. 87, Iss. 14
Open Access | Times Cited: 59
Protein tyrosine phosphatase 1B (PTP1B) as a potential therapeutic target for neurological disorders
Jordi Olloquequi, Amanda Cano, Elena Sánchez‐López, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 155, pp. 113709-113709
Open Access | Times Cited: 39
Dexmedetomidine Provides Protection Against Hippocampal Neuron Apoptosis and Cognitive Impairment in Mice with Alzheimer’s Disease by Mediating the miR-129/YAP1/JAG1 Axis
Weiying Sun, Jun Zhao, Chunzhi Li
Molecular Neurobiology (2020) Vol. 57, Iss. 12, pp. 5044-5055
Closed Access | Times Cited: 58
Squalamine and trodusquemine: two natural products for neurodegenerative diseases, from physical chemistry to the clinic
Ryan Limbocker, Silvia Errico, Denise Barbut, et al.
Natural Product Reports (2021) Vol. 39, Iss. 4, pp. 742-753
Open Access | Times Cited: 44
Interorganelle communication, aging, and neurodegeneration
Maja Petković, Caitlin E. O’Brien, Yuh Nung Jan
Genes & Development (2021) Vol. 35, Iss. 7-8, pp. 449-469
Open Access | Times Cited: 43
Protein Tyrosine Phosphatase 1B (PTP1B): A Comprehensive Review of Its Role in Pathogenesis of Human Diseases
Dominika Kołodziej, Łukasz Sobczak, Krzysztof Z. Łączkowski
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7033-7033
Open Access | Times Cited: 7
True or false? Alzheimer’s disease is type 3 diabetes: Evidences from bench to bedside
Yong Peng, Shun-yu Yao, Quan Chen, et al.
Ageing Research Reviews (2024) Vol. 99, pp. 102383-102383
Open Access | Times Cited: 7
From Marine Metabolites to the Drugs of the Future: Squalamine, Trodusquemine, Their Steroid and Triterpene Analogues
О. Б. Казакова, G. V. Giniyatullina, Denis A. Babkov, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1075-1075
Open Access | Times Cited: 22
GSK3-Driven Modulation of Inflammation and Tissue Integrity in the Animal Model
Friederike Kühl, Korbinian Brand, Ralf Lichtinghagen, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8263-8263
Open Access | Times Cited: 4
Deciphering Potent Protein Tyrosine Phosphatase‐1B Inhibitors Through In silico Molecular Docking, MMGBSA, and Molecular Dynamics
Vishnu Malakar, Dhanabal Palanisamy, Bryan Gowramma, et al.
ChemistrySelect (2025) Vol. 10, Iss. 4
Closed Access
Natural aminosterols inhibit NMDA receptors with low nanomolar potency
Giulia Fani, Elisabetta Coppi, Silvia Errico, et al.
FEBS Journal (2025)
Open Access
Mini‐review: Role of the PI3K/Akt pathway and tyrosine phosphatases in Alzheimer's disease susceptibility
David Curtis, Sreejan Bandyopadhyay
Annals of Human Genetics (2020) Vol. 85, Iss. 1, pp. 1-6
Open Access | Times Cited: 29
Overexpression of forebrain PTP1B leads to synaptic and cognitive impairments in obesity
Xing Ge, Minmin Hu, Menglu Zhou, et al.
Brain Behavior and Immunity (2024) Vol. 117, pp. 456-470
Closed Access | Times Cited: 3
Exploring the Multi‐Target Effects of Valeriana officinalis in Alzheimer's Disease: a Network Pharmacology Approach
Vishnu Malakar, Dhanabal Palanisamy, Antony Justin, et al.
ChemistrySelect (2025) Vol. 10, Iss. 15
Closed Access
Making biological membrane resistant to the toxicity of misfolded protein oligomers: a lesson from trodusquemine
Silvia Errico, Giacomo Lucchesi, Davide Odino, et al.
Nanoscale (2020) Vol. 12, Iss. 44, pp. 22596-22614
Open Access | Times Cited: 24
SARS-CoV-2 and the central nervous system: Emerging insights into hemorrhage-associated neurological consequences and therapeutic considerations
Joy Mitra, Manohar Kodavati, Vincent E. Provasek, et al.
Ageing Research Reviews (2022) Vol. 80, pp. 101687-101687
Open Access | Times Cited: 16
Can Allostery Be a Key Strategy for Targeting PTP1B in Drug Discovery? A Lesson from Trodusquemine
Rosanna Maccari, Rosaria Ottanà
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9621-9621
Open Access | Times Cited: 8
Abnormal phosphorylation of protein tyrosine in neurodegenerative diseases
Lijuan Shu, Chunfu Du, Yunxia Zuo
Journal of Neuropathology & Experimental Neurology (2023) Vol. 82, Iss. 10, pp. 826-835
Closed Access | Times Cited: 8
Identification of New Targets and the Virtual Screening of Lignans against Alzheimer’s Disease
Mayara dos Santos Maia, Gabriela Cristina Soares Rodrigues, Natália Ferreira de Sousa, et al.
Oxidative Medicine and Cellular Longevity (2020) Vol. 2020, pp. 1-19
Open Access | Times Cited: 22
Tyrosine phosphatase PTP1B impairs presynaptic NMDA receptor-mediated plasticity in a mouse model of Alzheimer's disease
Li Zhang, Zhaohong Qin, Fariba Sharmin, et al.
Neurobiology of Disease (2021) Vol. 156, pp. 105402-105402
Open Access | Times Cited: 20
The role and therapeutic implication of protein tyrosine phosphatases in Alzheimer’s disease
Xia Zhao, Xiong Li, Lingyu She, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 151, pp. 113188-113188
Open Access | Times Cited: 12
Recent Developments in the Role of Protein Tyrosine Phosphatase 1B (PTP1B) as a Regulator of Immune Cell Signalling in Health and Disease
Neve Read, Heather M. Wilson
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7207-7207
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top